Evidence map›Paper›PMID 41078583›Full record

ArticleJAR life2025

Dementia risk prediction in the general population: external validation of a prediction model in the population-based LifeLines Cohort Study.

Ingeborg Frentz, Sofia Marcolini, Silvan Licher, Peter Paul De Deyn, Mohammad Arfan Ikram

Abstract read
In one paragraph

Article in JAR life, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ingeborg FrentzDepartment of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.
Sofia MarcoliniDepartment of Neurology, UMCG, Groningen, the Netherlands.
Silvan LicherDepartment of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.
Peter Paul De DeynDepartment of Neurology, UMCG, Groningen, the Netherlands.
Mohammad Arfan IkramDepartment of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Models for dementia prediction in primary care are necessary to identify individuals at risk for developing dementia, but their implementation in clinical practice is partly limited due to lack of external validation or use of high-cost variables. We externally validated the predictive performance of a simple yet promising dementia risk prediction model. Methods: We assessed discriminative ability with a Results: Mean follow-up at LifeLines timepoint 1b was 1.5 years, mean follow-up at LifeLines timepoint 2a was 3.3 years and mean follow-up at LifeLines timepoint 3a was 9.1 years. Overall, 36 participants self-reported dementia development. Discriminative ability of the model overall dementia development yielded a Conclusion: In this study the basic dementia risk prediction model overestimated the risk of dementia, but had reasonable discriminative ability in the Lifelines cohort. Within this validation cohort the potential of the model is underestimated due to low incidence of reported dementia. Further validation is required to determine the true value of the model. Studies assessing its implementation feasibility in primary care should also be conducted.

Indexed as

AlzheimerDementiaPredictionPrimary carePrognosis

Identifiers

PMID41078583
PMCPMC12508850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.